 | Oncternal Therapeutics, Inc. | |||
| NCM : ONCT || Location: United States | ||||
$8.86+0.26 (+3.02%) |
0.0 M | 8.6 - 9.02 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.017 M |
| March 15, 2024 | 0.015 M |
| Feb. 29, 2024 | 0.016 M |
| Feb. 15, 2024 | 0.022 M |
| Jan. 31, 2024 | 0.025 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -3.13 | -3.11 | 0.60% |
| 09/30/2023 | -2.96 | -3.40 | -14.94% |
| 06/30/2023 | -0.16 | -0.15 | 8.09% |
| 03/31/2023 | -0.21 | -0.20 | 3.57% |
| 12/31/2022 | -0.21 | -0.20 | 5.88% |
ONCT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 2.960M | Shares Float | 2.651M |
| Short Float | 0.017M | Market Cap | 26.23M |
| Institution ownership | 16.12% | Insider ownership | 8.750% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -13.43 | Forward EPS | -10.25 |